A meta‐analysis of the association between Helicobacter pylori infection and risk of atherosclerotic cardiovascular disease.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12761
- By:
- Publication type:
- Article
Works matching IS 10834389 AND DT 2020 AND VI 25 AND IP 6
Results: 13
1
2
Issue Information.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12627
- Publication type:
- Article
3
Dendritic cell‐derived TGF‐β mediates the induction of mucosal regulatory T‐cell response to Helicobacter infection essential for maintenance of immune tolerance in mice.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12763
- By:
- Publication type:
- Article
4
A comparative study of 14‐day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first‐line Helicobacter pylori infection eradication: A randomized trial.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12762
- By:
- Publication type:
- Article
5
The relation between Helicobacter pylori immunoglobulin G seropositivity and leukocyte telomere length in US adults from NHANES 1999‐2000.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12760
- By:
- Publication type:
- Article
6
Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12756
- By:
- Publication type:
- Article
7
Efficacy of a novel sequential treatment regimen containing bismuth for Helicobacter pylori eradication in Turkish children.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12757
- By:
- Publication type:
- Article
8
Efficacy of bismuth‐based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large‐scale prospective, single‐center clinical trial in China.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12755
- By:
- Publication type:
- Article
9
Helicobacter pylori infection and eradication: Exploring their impacts on the gastrointestinal microbiota.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12754
- By:
- Publication type:
- Article
10
Duodenal microbiome in patients with or without Helicobacter pylori infection.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12753
- By:
- Publication type:
- Article
11
CRHP Finder, a webtool for the detection of clarithromycin resistance in Helicobacter pylori from whole‐genome sequencing data.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12752
- By:
- Publication type:
- Article
12
Clinical and economic impact of "triple therapy" for Helicobacter pylori eradication on peptic ulcer disease in Australia.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12751
- By:
- Publication type:
- Article
13
The outward shift of clarithromycin binding to the ribosome in mutant Helicobacter pylori strains.
- Published in:
- Helicobacter, 2020, v. 25, n. 6, p. 1, doi. 10.1111/hel.12731
- By:
- Publication type:
- Article